HCPCS Level II › J

HCPCS Level II codes starting with J

1,255 codes, page 9 of 13. Every code ever valid for billing is listed, including those now retired.

CodeDescriptionStatus
J7110 Infusion, dextran 75, 500 ml Valid
J7120 Ringers lactate infusion, up to 1000 cc Valid
J7121 5% dextrose in lactated ringers infusion, up to 1000 cc Valid
J7131 Hypertonic saline solution, 1 ml Valid
J7165 Injection, prothrombin complex concentrate, human-lans, per i.u. of factor ix activity Valid
J7168 Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity Valid
J7169 Injection, coagulation factor xa (recombinant), inactivated-zhzo (andexxa), 10 mg Valid
J7170 Injection, emicizumab-kxwh, 0.5 mg Valid
J7171 Injection, adamts13, recombinant-krhn, 10 iu Valid
J7172 Injection, marstacimab-hncq, 0.5 mg Valid
J7173 Injection, concizumab-mtci, 0.5 mg Valid
J7174 Injection, fitusiran, 0.04 mg Valid
J7175 Injection, factor x, (human), 1 i.u. Valid
J7176 Injection, human fibrinogen - chmt (fesilty), 1 mg Valid
J7177 Injection, human fibrinogen concentrate (fibryga), 1 mg Valid
J7178 Injection, human fibrinogen concentrate, not otherwise specified, 1 mg Valid
J7179 Injection, von willebrand factor (recombinant), (vonvendi), 1 i.u. vwf:rco Valid
J7180 Injection, factor xiii (antihemophilic factor, human), 1 i.u. Valid
J7181 Injection, factor xiii a-subunit, (recombinant), per iu Valid
J7182 Injection, factor viii, (antihemophilic factor, recombinant), (novoeight), per iu Valid
J7183 Injection, von willebrand factor complex (human), wilate, 1 i.u. vwf:rco Valid
J7185 Injection, factor viii (antihemophilic factor, recombinant) (xyntha), per i.u. Valid
J7186 Injection, antihemophilic factor viii/von willebrand factor complex (human), per factor viii i.u. Valid
J7187 Injection, von willebrand factor complex (humate-p), per iu vwf:rco Valid
J7188 Injection, factor viii (antihemophilic factor, recombinant), (obizur), per i.u. Valid
J7189 Factor viia (antihemophilic factor, recombinant), (novoseven rt), 1 microgram Valid
J7190 Factor viii (antihemophilic factor, human) per i.u. Valid
J7191 Factor viii (antihemophilic factor (porcine)), per i.u. Valid
J7192 Factor viii (antihemophilic factor, recombinant) per i.u., not otherwise specified Valid
J7193 Factor ix (antihemophilic factor, purified, non-recombinant) per i.u. Valid
J7194 Factor ix, complex, per i.u. Valid
J7195 Injection, factor ix (antihemophilic factor, recombinant) per iu, not otherwise specified Valid
J7196 Injection, antithrombin recombinant, 50 i.u. Valid
J7197 Antithrombin iii (human), per i.u. Valid
J7198 Anti-inhibitor, per i.u. Valid
J7199 Hemophilia clotting factor, not otherwise classified Valid
J7200 Injection, factor ix, (antihemophilic factor, recombinant), rixubis, per iu Valid
J7201 Injection, factor ix, fc fusion protein, (recombinant), alprolix, 1 i.u. Valid
J7202 Injection, factor ix, albumin fusion protein, (recombinant), idelvion, 1 i.u. Valid
J7203 Injection factor ix, (antihemophilic factor, recombinant), glycopegylated, (rebinyn), 1 iu Valid
J7204 Injection, factor viii, antihemophilic factor (recombinant), (esperoct), glycopegylated-exei, per iu Valid
J7205 Injection, factor viii fc fusion protein (recombinant), per iu Valid
J7207 Injection, factor viii, (antihemophilic factor, recombinant), pegylated, 1 i.u. Valid
J7208 Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl, (jivi), 1 i.u. Valid
J7209 Injection, factor viii, (antihemophilic factor, recombinant), (nuwiq), 1 i.u. Valid
J7210 Injection, factor viii, (antihemophilic factor, recombinant), (afstyla), 1 i.u. Valid
J7211 Injection, factor viii, (antihemophilic factor, recombinant), (kovaltry), 1 i.u. Valid
J7212 Factor viia (antihemophilic factor, recombinant)-jncw (sevenfact), 1 microgram Valid
J7213 Injection, coagulation factor ix (recombinant), ixinity, 1 i.u. Valid
J7214 Injection, factor viii/von willebrand factor complex, recombinant (altuviiio), per factor viii i.u. Valid
J7294 Segesterone acetate and ethinyl estradiol 0.15mg, 0.013mg per 24 hours; yearly vaginal system, each Valid
J7295 Ethinyl estradiol and etonogestrel 0.015mg, 0.12mg per 24 hours; monthly vaginal ring, each Valid
J7296 Levonorgestrel-releasing intrauterine contraceptive system, (kyleena), 19.5 mg Valid
J7297 Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg Valid
J7298 Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg Valid
J7299 Intrauterine copper contraceptive (miudella) Valid
J7300 Intrauterine copper contraceptive (paragard) Valid
J7301 Levonorgestrel-releasing intrauterine contraceptive system (skyla), 13.5 mg Valid
J7302 Levonorgestrel-releasing intrauterine contraceptive system, 52 mg through FY2026 Terminated
J7303 Contraceptive supply, hormone containing vaginal ring, each through FY2026 Terminated
J7304 Contraceptive supply, hormone containing patch, each Valid
J7306 Levonorgestrel (contraceptive) implant system, including implants and supplies Valid
J7307 Etonogestrel (contraceptive) implant system, including implant and supplies Valid
J7308 Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) Valid
J7309 Methyl aminolevulinate (mal) for topical administration, 16.8%, 1 gram through FY2026 Terminated
J7310 Ganciclovir, 4.5 mg, long-acting implant through FY2026 Terminated
J7311 Injection, fluocinolone acetonide, intravitreal implant (retisert), 0.01 mg Valid
J7312 Injection, dexamethasone, intravitreal implant, 0.1 mg Valid
J7313 Injection, fluocinolone acetonide, intravitreal implant (iluvien), 0.01 mg Valid
J7314 Injection, fluocinolone acetonide, intravitreal implant (yutiq), 0.01 mg Valid
J7315 Mitomycin, ophthalmic, 0.2 mg Valid
J7316 Injection, ocriplasmin, 0.125 mg Valid
J7318 Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg Valid
J7320 Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg Valid
J7321 Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose Valid
J7322 Hyaluronan or derivative, hymovis or hymovis one, for intra-articular injection, 1 mg Valid
J7323 Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose Valid
J7324 Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose Valid
J7325 Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg Valid
J7326 Hyaluronan or derivative, gel-one, for intra-articular injection, per dose Valid
J7327 Hyaluronan or derivative, monovisc, for intra-articular injection, per dose Valid
J7328 Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg Valid
J7329 Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg Valid
J7330 Autologous cultured chondrocytes, implant Valid
J7331 Hyaluronan or derivative, synojoynt, for intra-articular injection, 1 mg Valid
J7332 Hyaluronan or derivative, triluron, for intra-articular injection, 1 mg Valid
J7333 Hyaluronan or derivative, visco-3, for intra-articular injection, per dose through FY2026 Terminated
J7335 Capsaicin 8% patch, per 10 square centimeters through FY2026 Terminated
J7336 Capsaicin 8% patch, per square centimeter Valid
J7340 Carbidopa 5 mg/levodopa 20 mg enteral suspension, 100 ml Valid
J7342 Instillation, ciprofloxacin otic suspension, 6 mg Valid
J7345 Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg Valid
J7351 Injection, bimatoprost, intracameral implant, 1 microgram Valid
J7352 Afamelanotide implant, 1 mg Valid
J7353 Anacaulase-bcdb, 8.8% gel, 1 gram Valid
J7354 Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 mg) Valid
J7355 Injection, travoprost, intracameral implant, 1 microgram Valid
J7356 Injection, foscarbidopa 0.25 mg/foslevodopa 5 mg Valid
J7401 Mometasone furoate sinus implant, 10 micrograms through FY2026 Terminated
J7402 Mometasone furoate sinus implant, (sinuva), 10 micrograms Valid
Page 9 of 13